Marimed (MRMD) Other Non-Current Assets (2013 - 2026)
Marimed (MRMD) reported Other Non-Current Assets of $1.8 million for Q1 2026, up 61.29% year-over-year from $1.1 million in Q1 2025, and up 20.0% quarter-over-quarter from $1.5 million in Q4 2025.
Marimed (MRMD) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Marimed (MRMD) has 14 years of Other Non-Current Assets data on file, last reported at $1.8 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $1.8 million, up 61.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (up 61.29% YoY), and the FY2025 annual result was $1.5 million, down 86.63% from the prior year.
- Other Non-Current Assets rose to $1.8 million in Q1 2026 per MRMD's latest filing, from $1.5 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $13.0 million in Q1 2024 and troughed at $98000.0 in Q1 2022.
- A 5-year average of $4.8 million and a median of $1.4 million in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets surged 1229.59% in 2023, then slumped 91.39% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $1.0 million in 2022, then soared by 1124.32% to $12.5 million in 2023, then decreased by 10.51% to $11.2 million in 2024, then slumped by 86.63% to $1.5 million in 2025, then increased by 20.0% to $1.8 million in 2026.
- Business Quant data shows MRMD's Other Non-Current Assets at $1.8 million in Q1 2026, $1.5 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Marimed | - | - | 15.28 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.80 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 11.22 Mn |
| Sep 30, 2024 | 11.10 Mn |
| Jun 30, 2024 | 11.10 Mn |
| Mar 31, 2024 | 12.96 Mn |
| Dec 31, 2023 | 12.54 Mn |
| Sep 30, 2023 | 11.61 Mn |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 491,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | 98,000.00 |
| Sep 30, 2021 | 97,951.00 |
| Jun 30, 2021 | 97,950.00 |